Krsnaa Diagnostics Ltd

NSE
KRSNAA •
BUY

1W Return

-%

1M Return

-%

6M Return

-%

1Y Return

-%

3Y Return

-%

Start SIP in Krsnaa Diagnostics Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
82.47% Gain from 52W Low
2
TTM PE Ratio
Above industry Median
36.9
Price to Book Ratio
Below industry Median
2.8
Dividend yield 1yr %
Below industry Median
0.4
TTM PEG Ratio
PEG TTM is negative
-5.5
RSI
RSI is mid-range
33.8
MFI
MFI strongly Oversold
19.8

Krsnaa Diagnostics Ltd Key Financials

*All values are in ₹ Cr.

Krsnaa Diagnostics Ltd shareholding Pattern

Promoter
27%
Foreign Institutions
3.4%
Mutual Funds
11.9%
Domestic Institutions
16.6%
Public
52.9%

Krsnaa Diagnostics Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
2
Bearish Moving Averages
14
5Day EMA
664.70
10Day EMA
673.60
12Day EMA
676.20
20Day EMA
683.40
26Day EMA
686.60
50Day EMA
689.40
100Day EMA
675.50
200Day EMA
637.60
Delivery & Volume
Resistance & Support
653.57
Pivot
Resistance
First Resistance
662.23
Second Resistance
672.67
Third Resistance
681.33
Support
First Support
643.13
Second support
634.47
Third Support
624.03
Relative Strength Index
33.75
Money Flow Index
19.83
MACD
-10.35
MACD Signal
-6.13
Average True Range
22.37
Average Directional Index
17.42
Rate of Change (21)
-6.51
Rate of Change (125)
4.87

Krsnaa Diagnostics Ltd Company background

Founded in: 2010
Managing director: Pallavi Bhatevara,
Krsnaa Diagnostics Limited was originally incorporated as Krsna Diagnostics Private Limited at Pune, Maharashtra as a private limited company under the Companies Act, 1956, pursuant to a certificate of incorporation dated 22 December 2010. The name of the Company was subsequently changed to Krsnaa Diagnostics Private Limited, pursuant to a fresh certificate of incorporation issued by the RoC on 29 January 2015. Thereafter, the Company was converted into a public limited company pursuant to a special resolution passed in the extraordinary general meeting of the Shareholders of our Company held on 25 April 2021 and consequently the name of the Company was changed to its present name pursuant to a fresh certificate of incorporation issued by the RoC on 06 May 2021. The company is primarily engaged in providing diagnostic services centres all over India.The company is providing Radiology and Pathology services for Xray,CT scan,MRI,Mammography,TeleReporting services,all type of blood and urine investigation and other related diagnostic services. The company owns an extensive network of integrated diagnostics centres across India primarily in nonmetro and lowertier cities and towns,with operating 1823 diagnostics centres offering radiology and pathology services in 13 states across the country.The company focuses on the publicprivate partnership(PPP) diagnostics segment and has the largest presence in the diagnostic PPP segment.During the FY2019, the Company has issued 1000 equity shares of face value of Rs. 10/ each at an offer price of Rs. 328.9597 (including Security Premium of Rs. 318.9597/). The company also issued 30,38,886 Compulsory Convertible Participating Preference Shares CCPS of face value of Rs. 250 each at an offer price of Rs. 328.9597 (including Security Premium of Rs. 78.9597). During the FY2021,the company has allotted 730904 equity shares of Rs 10 each through rights issue. Also the company undertook the conversion of 600960 CCPS Series B into equity shares in the ratio of 1:1 at a price of Rs 250 per share(including the premium of Rs 240 per share). The company,pursuant to a shareholders resolution dated 25 April 2021,subdivided the face value of equity shares from Rs 10 to Rs 5 per share.During the month of August 2021,the company came out with Rs 1213.33 crore IPO which comprised a fresh issue of Rs 400 crore and an offer for sale of Rs 813.33 crore by selling shareholders,including PHI Capital Trust,Kitara and Somerset Indus Healthcare Fund.The company will utilise the fresh issue proceeds for establishing diagnostics centres in Punjab,Karnataka,Himachal Pradesh and Maharashtra and also repaying of debts.The allotted shares were listed on the BSE Ltd and National Stock Exchange of India(NSE) on 16 August 2021.
Read More

Krsnaa Diagnostics Ltd FAQs

Krsnaa Diagnostics Ltd shares are currently priced at 651.8 on NSE and 651.2 on BSE as of 2/28/2024 12:00:00 AM. Please be aware that stock prices are subject to continuous fluctuations due to various factors.

The past 1-year return of Krsnaa Diagnostics Ltd [KRSNAA] share was 80.27. The Krsnaa Diagnostics Ltd [KRSNAA] share hit a 1-year low of Rs. 357.2 and a 1-year high of Rs. 767.9.

The market cap of Krsnaa Diagnostics Ltd is Rs. 2104.65 Cr. as of 2/28/2024 12:00:00 AM.

The PE ratios of Krsnaa Diagnostics Ltd is 40.47 as of 2/28/2024 12:00:00 AM.

The PB ratios of Krsnaa Diagnostics Ltd is 2.76 as of 2/28/2024 12:00:00 AM

The Mutual Fund Shareholding was 11.89% at the end of 2/28/2024 12:00:00 AM.

You can easily buy Krsnaa Diagnostics Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
or Resume your Application
+91 -

personImage